Montreal biotech company announces first sale of biosynthetic CBD

CanadaLeave a Comment

Following up on encouraging news in August from Willow Biosciences about its large production runs of biosynthetic cannabigerol (CBG), another biotechnology company has announced the first sale of CBD produced using a similar fermentation process. Hyasynth, based in Montreal, used a proprietary yeast strain it modified to contain the genes from cannabis responsible for synthesizing […]

Montreal biotech company announces first sale of biosynthetic CBD is a post from: Marijuana Business Daily: Financial, Legal & Cannabusiness news for cannabis entrepreneurs

Leave a Reply

Your email address will not be published. Required fields are marked *